Cargando…

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation

Detalles Bibliográficos
Autor principal:	Reiffel, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MediaSphere Medical 2018
Materias:	Research Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252812/ https://www.ncbi.nlm.nih.gov/pubmed/32494480 http://dx.doi.org/10.19102/icrm.2018.091201

Ejemplares similares

Antiarrhythmic Drugs for Atrial Fibrillation: Selected Features of Ventricular Repolarization That Facilitate Proarrhythmic Torsades de Pointes and Favor Inpatient Initiation
por: Reiffel, James A.
Publicado: (2021)

Going Beyond Antiarrhythmic–Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient
por: Reiffel, James A.
Publicado: (2019)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
por: Stazi, Filippo
Publicado: (2020)

Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?
por: Reiffel, James A.
Publicado: (2020)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants
por: Wu, Victor Chien-Chia, et al.
Publicado: (2023)

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2012)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
por: Wang, Amy
Publicado: (2012)

Direct Effects of Activation and Inhibition of the Coagulation System on the Atrial Fibrillation Substrate: Is Anticoagulation Antiarrhythmic?
por: Nattel, Stanley
Publicado: (2016)

Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey
por: Reiffel, James A, et al.
Publicado: (2023)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

Comparison of Circumferential Pulmonary Vein Isolation and Antiarrhythmic Drug Therapy in Patients with Atrial Fibrillation
por: Xu, Yanmin, et al.
Publicado: (2012)

Clinically Important Drug–Drug Interactions Between Antiarrhythmic Drugs and Anticoagulants
por: Konieczny, Kaja M., et al.
Publicado: (2019)

Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation
por: Verrier, Richard L., et al.
Publicado: (2020)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on Antiarrhythmic-Drug Therapy
por: Afsin, Abdulmecit, et al.
Publicado: (2021)

Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation
por: Kuniss, Malte, et al.
Publicado: (2021)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
por: Hwang, Inseok, et al.
Publicado: (2022)

Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not
por: Reiffel, James A.
Publicado: (2019)

When Silence Isn’t Golden: The Case of “Silent” Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2017)

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
por: Carlisle, Matthew A., et al.
Publicado: (2022)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
por: Geng, Meng, et al.
Publicado: (2020)

Correction to: Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on Antiarrhythmic-Drug Therapy
por: Afsin, Abdulmecit, et al.
Publicado: (2021)

Meta‐analysis of cryoballoon ablation versus antiarrhythmic drugs as initial therapy for symptomatic atrial fibrillation
por: Mao, Yin‐jun, et al.
Publicado: (2021)

Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease
por: Pantlin, Peter G., et al.
Publicado: (2020)

Editorial: Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps
por: Reiffel, James A
Publicado: (2014)

Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden
por: Dan, Gheorghe-Andrei
Publicado: (2020)

Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs
por: Park, Yoon Jung, et al.
Publicado: (2023)

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
por: Tardos, Jonathan G., et al.
Publicado: (2021)

Revisiting an Underrecognized Strategy for Rhythm Management: Hybrid Therapy for Patients who Convert from Atrial Fibrillation to Flutter on Antiarrhythmic Drugs
por: Riad, Fady S., et al.
Publicado: (2019)

Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design
por: Packer, Douglas L., et al.
Publicado: (2018)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation—Insights from the German Ablation Registry
por: Schleberger, Ruben, et al.
Publicado: (2021)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Maraj, Ilir, et al.
Publicado: (2018)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dr07aaspo2nvvrg6urjnka97hj